- New, Persistent Opioid Use Common after Surgery
New, Persistent Opioid Use Common after Surgery
Among about 36,000 patients, approximately 6 percent continued to use opioids more than three months after their surgery, with rates not differing between major and minor surgical procedures, according to a study published by JAMA Surgery.
Millions of Americans undergo surgery each year, and many patients receive their first exposure to opioids following surgery. Despite increased focus on reducing opioid prescribing for long-term pain, little is known regarding the incidence and risk factors for persistent opioid use after surgery. Chad M. Brummett, M.D., of the University of Michigan Medical School, Ann Arbor, and colleagues used nationwide insurance claims data set from 2013 to 2014 to identify U.S. adults (ages 18 to 64 years) without opioid use in the year prior to surgery. For patients filling a perioperative opioid prescription, the researchers calculated the incidence of persistent opioid use for more than 90 days among patients who had not used opioids previously, after both minor and major surgical procedures, and assessed data for patient-level predictors of persistent opioid use.
A total of 36,177 patients met the inclusion criteria, with 29,068 (80 percent) receiving minor surgical procedures and 7,109 (20 percent) receiving major procedures. The group had an average age of 45 years and was predominately female (66 percent) and white (72 percent). The rates of new persistent opioid use were similar between the two groups, ranging from 5.9 percent to 6.5 percent. By comparison, the incidence in the nonoperative control group was only 0.4 percent. Risk factors independently associated with new persistent opioid use included preoperative tobacco use, alcohol and substance abuse disorders, mood disorders, anxiety, and preoperative pain disorders.
“New persistent opioid use after surgery is common and is not significantly different between minor and major surgical procedures but rather associated with behavioral and pain disorders. This suggests its use is not due to surgical pain but addressable patient-level predictors. New persistent opioid use represents a common but previously underappreciated surgical complication that warrants increased awareness,” the authors write.
(JAMA Surgery. Published online April 12, 2017.doi:10.1001/jamasurg.2017.0504.
DISCLAIMER: Bankix Systems Ltd is the registered name of a Canadian firm since 2003, and bankixsystems.com is its OFFICIAL website. Besides these entities, we have no relationship with anyone, business, website, or any other entity anywhere in the world, claiming to be Bankix Systems, or using a similar name, and creating the impression that it has some connection with our company. We do not endorse and are therefore, not responsible for any act or lack thereof by any such entity. Bankix Systems Ltd is also not responsible for the content of the description of products and services linked to our site nor does it necessarily endorse them. The information here provided is not for diagnosing/treating your health concerns. Kindly contact your doctor or health care professional for all your healthcare requirements.
Contents © 2003-2019, BankixSystems.com. All rights reserved. Unauthorized reproduction strictly prohibited. Information based on best available resources. Opinions are current and subject to change.